Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?
Pharmacopsychiatry · 01.01.2025 · 58 (01) · 14-24
DOI: 10.1055/a-2331-7684 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacopsychiatry, erschienen am 01.01.2025. Verfasst von Mohsen Khosravi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. Hauptthemen laut MEDLINE: Gastrointestinal Diseases, Psychiatry. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 99 Literaturangaben.
Abstract (Originalsprache)
Currently, it has been stated that psychiatric and psychological problems are equally paramount aspects of the clinical modulation and manifestation of both the central nervous and digestive systems, which could be used to restore balance. The present narrative review aims to provide an elaborate description of the bio-psycho-social facets of refractory functional gastrointestinal disorders, psychiatrists’ role, specific psychiatric approach, and the latest psychiatric and psychological perspectives on practical therapeutic management. In this respect, “psyche,” “psychiatry,” “psychology,” “psychiatrist,” “psychotropic,” and “refractory functional gastrointestinal disorders” (as the keywords) were searched in relevant English publications from January 1, 1950, to March 1, 2024, in the PubMed, Web of Science, Scopus, EMBASE, Cochrane Library, and Google Scholar databases. Eventually, the narrative technique was adopted to reach a compelling story with a high level of cohesion through material synthesis. The current literature recognizes the brain-gut axis modulation as a therapeutic target for refractory functional gastrointestinal disorders and the bio-psycho-social model as an integrated framework to explain disease pathogenesis. The results also reveal some evidence to affirm the benefits of psychotropic medications and psychological therapies in refractory functional gastrointestinal disorders, even when psychiatric symptoms were absent. It seems that psychiatrists are required to pay higher levels of attention to both the assessment and treatment of patients with refractory functional gastrointestinal disorders, accompanied by educating and training practitioners who take care of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
- Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
- Department of Orthopedic and Spine Surgeon, Taif University, Taif, Saudi Arabia.
- Department of Biotechnology, College of Applied Sciences, University of Fallujah, Al-anbar, Iraq.
- Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- National University of Science and Technology, Dhi Qar, Iraq.
Zitieren
APA
Khosravi, M., Alzahrani, A. A., Muhammed, T. M., Hjazi, A., Abbas, H. H., AbdRabou, M. A., Mohmmed, K. H., Ghildiyal, P., Yumashev, A., Elawady, A., & Sarabandi, S. (2025). Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?. Pharmacopsychiatry, 58(01), 14-24. https://doi.org/10.1055/a-2331-7684
Vancouver
Khosravi M, Alzahrani AA, Muhammed TM, Hjazi A, Abbas HH, AbdRabou MA, et al. Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?. Pharmacopsychiatry. 2025;58(01):14-24. doi:10.1055/a-2331-7684
BibTeX
@article{Khosravi2025,
author = {Khosravi, Mohsen and Alzahrani, Abdullah A and Muhammed, Thikra M and Hjazi, Ahmed and Abbas, Huda H and AbdRabou, Mervat A and Mohmmed, Karrar H and Ghildiyal, Pallavi and Yumashev, Alexey and Elawady, Ahmed and Sarabandi, Sahel},
title = {Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?},
journal = {Pharmacopsychiatry},
year = {2025},
volume = {58},
number = {01},
pages = {14--24},
doi = {10.1055/a-2331-7684}
}
EUVIMED